DD251551A5 - Verfahren zur herstellung eines phenoxyessigsaeurederivates - Google Patents

Verfahren zur herstellung eines phenoxyessigsaeurederivates Download PDF

Info

Publication number
DD251551A5
DD251551A5 DD86293056A DD29305686A DD251551A5 DD 251551 A5 DD251551 A5 DD 251551A5 DD 86293056 A DD86293056 A DD 86293056A DD 29305686 A DD29305686 A DD 29305686A DD 251551 A5 DD251551 A5 DD 251551A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
group
hydrogen
amino
hydroxy
Prior art date
Application number
DD86293056A
Other languages
German (de)
English (en)
Inventor
Brian R Holloway
Ralph Howe
Balbir S Rao
Donald Stribling
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD251551A5 publication Critical patent/DD251551A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
DD86293056A 1985-07-30 1986-07-29 Verfahren zur herstellung eines phenoxyessigsaeurederivates DD251551A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519154A GB8519154D0 (en) 1985-07-30 1985-07-30 Aromatic ethers

Publications (1)

Publication Number Publication Date
DD251551A5 true DD251551A5 (de) 1987-11-18

Family

ID=10583042

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86293056A DD251551A5 (de) 1985-07-30 1986-07-29 Verfahren zur herstellung eines phenoxyessigsaeurederivates

Country Status (27)

Country Link
US (1) US4772631A (ko)
EP (1) EP0210849B1 (ko)
JP (2) JPH0651661B2 (ko)
KR (1) KR870001142A (ko)
CN (1) CN1014516B (ko)
AR (1) AR242176A1 (ko)
AT (1) ATE55980T1 (ko)
AU (1) AU603987B2 (ko)
CA (1) CA1283122C (ko)
CS (1) CS266593B2 (ko)
DD (1) DD251551A5 (ko)
DE (1) DE3673722D1 (ko)
DK (1) DK168761B1 (ko)
ES (1) ES2002720A6 (ko)
FI (1) FI88030C (ko)
GB (1) GB8519154D0 (ko)
GR (1) GR861994B (ko)
HU (1) HUT44757A (ko)
IE (1) IE60157B1 (ko)
IL (1) IL79447A0 (ko)
NO (1) NO170480C (ko)
NZ (1) NZ217011A (ko)
PH (1) PH22503A (ko)
PL (1) PL152320B1 (ko)
PT (1) PT83085B (ko)
SU (1) SU1632370A3 (ko)
ZA (1) ZA865097B (ko)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8905336D0 (en) * 1989-03-08 1989-04-19 Ici Plc Chemical compounds
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
KR920005952B1 (ko) * 1989-05-26 1992-07-25 이사무 이와이 오수정화조의 여과재 순환 정화장치
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
GB9016655D0 (en) * 1990-07-30 1990-09-12 Ici Plc Therapeutic agents
GB9111425D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9224740D0 (en) * 1992-11-26 1993-01-13 Ici Plc Therapeutic agents
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5488064A (en) * 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
US7709677B2 (en) * 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
WO2008106213A1 (en) * 2007-02-27 2008-09-04 Titan Pharmaceuticals, Inc. Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
WO2013130968A1 (en) * 2012-03-01 2013-09-06 University Of Cincinnati Ros-activated compounds as selective anti-cancer therapeutics
CN107205964A (zh) 2014-12-03 2017-09-26 威力塞帕特治疗股份有限公司 使用调节释放索拉贝隆用于下尿路症状的组合物和方法
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10065922B2 (en) 2015-10-23 2018-09-04 Velicept Therapeutics, Inc. Solabegron zwitterion and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE354851B (ko) * 1970-02-18 1973-03-26 Haessle Ab
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
CH632987A5 (en) * 1976-10-07 1982-11-15 Haessle Ab Process for preparing novel amines
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
ATE2265T1 (de) * 1979-10-25 1983-02-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes

Also Published As

Publication number Publication date
HUT44757A (en) 1988-04-28
DK359986A (da) 1987-01-31
IL79447A0 (en) 1986-10-31
IE60157B1 (en) 1994-06-15
GB8519154D0 (en) 1985-09-04
IE861827L (en) 1987-01-30
CN86105400A (zh) 1987-03-11
PL152320B1 (en) 1990-12-31
NO170480C (no) 1992-10-21
ES2002720A6 (es) 1988-10-01
DK168761B1 (da) 1994-06-06
AR242176A1 (es) 1993-03-31
NO863061L (no) 1987-02-02
AU6002986A (en) 1987-02-05
JPH0651661B2 (ja) 1994-07-06
FI88030B (fi) 1992-12-15
JPH0819062B2 (ja) 1996-02-28
CA1283122C (en) 1991-04-16
DK359986D0 (da) 1986-07-29
CS573586A2 (en) 1989-04-14
FI862896A (fi) 1987-01-31
DE3673722D1 (en) 1990-10-04
EP0210849B1 (en) 1990-08-29
PT83085B (pt) 1989-01-30
CN1014516B (zh) 1991-10-30
FI88030C (fi) 1993-03-25
SU1632370A3 (ru) 1991-02-28
NZ217011A (en) 1990-02-26
CS266593B2 (en) 1990-01-12
NO863061D0 (no) 1986-07-29
AU603987B2 (en) 1990-12-06
JPH06340597A (ja) 1994-12-13
JPS6277357A (ja) 1987-04-09
GR861994B (en) 1986-11-26
FI862896A0 (fi) 1986-07-09
PH22503A (en) 1988-09-12
EP0210849A1 (en) 1987-02-04
ZA865097B (en) 1987-03-25
PL260759A1 (en) 1988-09-15
KR870001142A (ko) 1987-03-11
PT83085A (en) 1986-08-01
ATE55980T1 (de) 1990-09-15
NO170480B (no) 1992-07-13
US4772631A (en) 1988-09-20

Similar Documents

Publication Publication Date Title
DD251551A5 (de) Verfahren zur herstellung eines phenoxyessigsaeurederivates
DE1493955B2 (de) Sulfonanilide und verfahren zu ihrer herstellung
DD283374A5 (de) Verfahren zur herstellung von 2-hydroxy-3-phenoxypropylaminoverbindungen
DE1643262A1 (de) Neue 1-Phenoxy-2-hydroxy-3-alkylaminopropane und Verfahren zu ihrer Herstellung
DE1941625C3 (de) Substituierte Phenylalkansäuren
DE2460689A1 (de) Neue substituierte propanol-(2)-derivate und deren nikotinsaeureester sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE1593901B2 (de) Basisch substituierte benzofurane oder indole und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
EP0243903A1 (de) Gegebenenfalls substituierte, 1-(w[bis-(Phenyl)-alkoxy]-alkyl)-4-(alkenyl)-piperazine und -4-(alkinyl)-piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2711981C2 (de) Phenäthylamin-Derivate und diese Verbindungen enthaltende bronchodilatorisch wirksame Mittel
EP0271013A2 (de) Basisch substituierte Phenylacetonitrile, ihre Herstellung und diese enthaltende Arzneimittel
DE68914336T2 (de) 1,2-Diarylethylamine zur Behandlung neurotoxischer Verletzungen.
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
DE69711911T2 (de) Aryloxypropanolaminderivate, verfahren zu deren herstellung und deren verwendungen
DD300542A5 (de) Chemische verbindungen
DE2834107A1 (de) Benzylalkoholderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DD298786A5 (de) Thiophene
DE2253748A1 (de) Carboxamidobenzoesaeuren
EP0013749A1 (de) Hexahydro-1,4-oxazepine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0167945B1 (de) Phenylethylaminopropiophenon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DD142875A5 (de) Verfahren zur herstellung von 2-aminoaethanolderivaten
AT256816B (de) Verfahren zur Herstellung von neuen substituierten 1-Phenyl-2-aminoalkanolen und deren Säureadditionssalzen
EP0109622B1 (de) 7-Phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepine, ihre Herstellung und Verwendung
DE2520644A1 (de) Neue benzoesaeurederivate
EP0035733B1 (de) Neue 1-(Acylamino-aryloxy-)2-hydroxy-3-alkinyl-aminopropane und Verfahren zu ihrer Herstellung
CH670638A5 (ko)

Legal Events

Date Code Title Description
RPI Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act)
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee